Loading clinical trials...
Loading clinical trials...
Phase 1 safety, pharmacokinetics, and pharmacodynamics trial of the focal adhesion kinase (FAK) inhibitor PF-04554878 in patients with advanced non-hematologic malignancies, including patients with ma...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Verastem, Inc.
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer
NCT06340568 · Endometrial Cancer
NCT06844383 · Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer)
NCT06713993 · Esophageal Cancer (EsC)
Pfizer Investigational Site
Boston, Massachusetts
Pfizer Investigational Site
Boston, Massachusetts
Pfizer Investigational Site
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions